National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 274180

Case Details

VAERS ID: 274180 (history)  
Form: Version 1.0  
Age: 13.0  
Gender: Female  
Location: Florida  
   Days after vaccination:0
Submitted: 2007-03-14
   Days after onset:49
Entered: 2007-03-16
   Days after submission:2
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 1425F / 1 - / IM

Administered by: Other       Purchased by: Other
Symptoms: Injection site rash, Rash generalised
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: Multiple allergies
Preexisting Conditions:
Diagnostic Lab Data: NONE
CDC Split Type: WAES0702USA00996

Write-up: Information has been received from a registered nurse, concerning a 13 year old female with multiple allergies, who on 23-JAN-2007 was vaccinated IM in the right arm, with the first dose of Gardasil (yeast) (Lot # 655165/1425F). There was no concomitant medication. Approximately five to ten minutes later, the patient developed a rash that "started at the injection site and then spread to the arm and the whole body." Treatment with ZYRTEC was immediately given in the office, and the patient was instructed to take BENADRYL at home, if needed. The nurse reported that "rash was mild and self-limiting," and remarked "it was easily treated with antihistamine and resolved soon after treatment was given." He clarified that "this was a mild reaction," and he did not feel the patients condition would have required hospitalization or threatened her safety. The mother of the patient wanted her daughter to receive the subsequent doses of the vaccine, however the nurse stated he felt the patient''s system was "sensitized" and believed a second dose would be "too risky." Additional information has been requested.

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166